Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer
- PMID: 26179096
- DOI: 10.1177/1040638715592445
Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer
Abstract
The aim of our study was to compare serum levels and protein tissue of human epidermal growth factor receptor-2 proto-oncogene (HER2) and mucin 1 (MUC1) using an antigen-capture enzyme-linked immunosorbent assay and immunohistochemistry (IHC) in canine mammary carcinomas and investigate how the 2 markers correlate with dogs with metastasis and without metastasis to a regional lymph node. Forty-eight female dogs were selected, including 14 with non-metastatic cancer, 14 with lymph node metastasis, and 20 healthy animals. Serum samples were collected from all the animals and tissues from 28 dogs with malignant mammary tumor with or without metastasis for evaluated HER2 and MUC1 expression. Tissue sample were evaluated for MUC1 and HER2 immunoexpression by IHC. The results showed measurable serum levels of MUC1 and HER2 in all groups. While serum MUC1 levels were significantly higher in animals with metastasis than the other 2 groups, no increase was observed in HER2 serum levels. The MUC1 IHC results showed that only membrane immunostaining was significantly different between the groups. Statistically, there was an association between immunostaining and the serum HER2 levels. Our results indicate that serum concentrations of HER2 and the IHC staining pattern for HER2 in primary tumor do not correlate with the presence of regional metastasis. However, increased concentrations of MUC1 in the serum of dogs with mammary cancer are associated with the presence of metastasis to regional lymph nodes. A membrane pattern of IHC staining for MUC1 in the primary tumor suggests that metastases to regional lymph node are present.
Keywords: Female dogs; mammary gland; neoplasia; tumor marker.
© 2015 The Author(s).
Similar articles
-
MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.Vet J. 2009 Dec;182(3):491-3. doi: 10.1016/j.tvjl.2008.09.007. Epub 2008 Oct 22. Vet J. 2009. PMID: 18948041
-
Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.J Vet Intern Med. 2015 Sep-Oct;29(5):1360-7. doi: 10.1111/jvim.13576. Epub 2015 Jun 30. J Vet Intern Med. 2015. PMID: 26130166 Free PMC article.
-
Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.J Comp Pathol. 2018 Jan;158:32-38. doi: 10.1016/j.jcpa.2017.11.001. Epub 2017 Dec 6. J Comp Pathol. 2018. PMID: 29422313
-
Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry.Vet Pathol. 2014 Jan;51(1):127-45. doi: 10.1177/0300985813509388. Epub 2013 Nov 13. Vet Pathol. 2014. PMID: 24227007 Review.
-
Canine mammary gland tumors.Vet Clin North Am Small Anim Pract. 2003 May;33(3):573-96. doi: 10.1016/s0195-5616(03)00020-2. Vet Clin North Am Small Anim Pract. 2003. PMID: 12852237 Review.
Cited by
-
Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study.Cancer Cell Int. 2022 Jan 9;22(1):14. doi: 10.1186/s12935-021-02398-6. Cancer Cell Int. 2022. PMID: 35000604 Free PMC article. Review.
-
HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas.Vet Sci. 2022 Oct 22;9(11):583. doi: 10.3390/vetsci9110583. Vet Sci. 2022. PMID: 36356060 Free PMC article.
-
CA 15-3, CRP, and LDH correlates with prognostic parameters in canine mammary neoplasms.Anim Reprod. 2023 Mar 13;20(1):e20220086. doi: 10.1590/1984-3143-AR2022-0086. eCollection 2023. Anim Reprod. 2023. PMID: 36938312 Free PMC article.
-
Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.Front Oncol. 2020 Apr 28;10:617. doi: 10.3389/fonc.2020.00617. eCollection 2020. Front Oncol. 2020. PMID: 32411603 Free PMC article. Review.
-
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.Breast Cancer Res Treat. 2018 Feb;167(3):635-648. doi: 10.1007/s10549-017-4548-2. Epub 2017 Oct 30. Breast Cancer Res Treat. 2018. PMID: 29086231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous